Literature DB >> 8755992

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion.

M A Bogoyevitch1, J Gillespie-Brown, A J Ketterman, S J Fuller, R Ben-Levy, A Ashworth, C J Marshall, P H Sugden.   

Abstract

It has recently been recognized that cellular stresses activate certain members of the mitogen-activated protein kinase (MAPK) superfamily. One role of these "stress-activated" MAPKs is to increase the transactivating activity of the transcription factors c-Jun, Elk1, and ATF2. These findings may be particularly relevant to hearts that have been exposed to pathological stresses. Using the isolated perfused rat heart, we show that global ischemia does not activate the 42- and 44-kD extracellular signal-regulated (protein) kinase (ERK) subfamily of MAPKs but rather stimulates a 38-kD activator of MAPK-activated protein kinase-2 (MAPKAPK2). This activation is maintained during reperfusion. The molecular characteristics of this protein kinase suggest that it is a member of the p38/reactivating kinase (RK) group of stress-activated MAPKs. In contrast, stress-activated MAPKs of the c-Jun N-terminal kinase (JNK/SAPKs) subfamily are not activated by ischemia alone but are activated by reperfusion following ischemia. Furthermore, transfection of ventricular myocytes with activated protein kinases (MEKK1 and SEK1) that may be involved in the upstream activation of JNK/ SAPKs induces increases in myocyte size and transcriptional changes typical of the hypertrophic response. We speculate that activation of multiple parallel MAPK pathways may be important in the responses of hearts to cellular stresses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755992     DOI: 10.1161/01.res.79.2.162

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  115 in total

1.  Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress.

Authors:  S Li; B P Chen; N Azuma; Y L Hu; S Z Wu; B E Sumpio; J Y Shyy; S Chien
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

2.  Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.

Authors:  N H Purcell; G Tang; C Yu; F Mercurio; J A DiDonato; A Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 3.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

4.  Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factors in rat ventricular myocytes.

Authors:  A Clerk; P H Sugden
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

5.  Transient anoxia and oxyradicals induce a region-specific activation of MAPKs in the embryonic heart.

Authors:  Stephany Gardier; Sarah Pedretti; Alexandre Sarre; Eric Raddatz
Journal:  Mol Cell Biochem       Date:  2010-03-21       Impact factor: 3.396

Review 6.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

7.  N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.

Authors:  Warren D Gray; Paolin Che; Milton Brown; Xinghai Ning; Niren Murthy; Michael E Davis
Journal:  J Cardiovasc Transl Res       Date:  2011-08-11       Impact factor: 4.132

8.  A novel cardioprotective p38-MAPK/mTOR pathway.

Authors:  Gonzalo Hernández; Hind Lal; Miguel Fidalgo; Ana Guerrero; Juan Zalvide; Thomas Force; Celia M Pombo
Journal:  Exp Cell Res       Date:  2011-10-02       Impact factor: 3.905

9.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

Authors:  Junichi Sadoshima; Olivier Montagne; Qian Wang; Guiping Yang; Jill Warden; Jing Liu; Gen Takagi; Vijaya Karoor; Chull Hong; Gary L Johnson; Dorothy E Vatner; Stephen F Vatner
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 10.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.